Congenic D1A Dopamine Receptor Mutants: Ethologically Based Resolution of Behavioural Topography Indicates Genetic Background as a Determinant of Knockout Phenotype
10.1038/sj.npp.1300008
Crossref journal-article
Springer Science and Business Media LLC
Neuropsychopharmacology (297)
Bibliography

McNamara, F. N., Clifford, J. J., Tighe, O., Kinsella, A., Drago, J., Croke, D. T., & Waddington, J. L. (2002). Congenic D1A Dopamine Receptor Mutants: Ethologically Based Resolution of Behavioural Topography Indicates Genetic Background as a Determinant of Knockout Phenotype. Neuropsychopharmacology, 28(1), 86–99.

Authors 7
  1. Fergal N McNamara (first)
  2. Jeremiah J Clifford (additional)
  3. Orna Tighe (additional)
  4. Anthony Kinsella (additional)
  5. John Drago (additional)
  6. David T Croke (additional)
  7. John L Waddington (additional)
References 36 Referenced 45
  1. Andringa G, Drukarch B, Leysen JE, Cools AR, Stoof JC (1999). The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors. Eur J Pharmacol 364: 33–41. (10.1016/S0014-2999(98)00825-5) / Eur J Pharmacol by G Andringa (1999)
  2. Arnt J, Hyttel J, Sanchez C (1992). Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur J Pharmacol 213: 259–267. (10.1016/0014-2999(92)90690-6) / Eur J Pharmacol by J Arnt (1992)
  3. Carter TA, Del Rio JA, Greenhall JA, Latronica ML, Lockhart DJ, Barlow C (2001). Chipping away at complex behavior: transcriptome/phenotype correlations in the mouse brain. Physiol Behav 73: 849–857. (10.1016/S0031-9384(01)00522-4) / Physiol Behav by TA Carter (2001)
  4. Clifford JJ, Kinsella A, Tighe O, Rubinstein M, Grandy DK, Low MJ et al (2001). Comparative, topographically based evaluation of behavioural phenotype and specification of D1-like:D2-like interactions in a line of incipient congenic mice with D2 dopamine receptor ‘knockout’. Neuropsychopharmacology 25: 527–536. (10.1016/S0893-133X(01)00246-9) / Neuropsychopharmacology by JJ Clifford (2001)
  5. Clifford JJ, Tighe O, Croke DT, Sibley DR, Drago J, Waddington JL (1998). Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax. Neuropharmacology 37: 1595–1602. (10.1016/S0028-3908(98)00116-6) / Neuropharmacology by JJ Clifford (1998)
  6. Clifford JJ, Tighe O, Croke DT, Kinsella A, Sibley DR, Drago J et al (1999). Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase. Neuroscience 93: 1483–1489. (10.1016/S0306-4522(99)00297-3) / Neuroscience by JJ Clifford (1999)
  7. Clifford JJ, Usiello A, Vallone D, Kinsella A, Borrelli E, Waddington JL (2000). Topographical evaluation of behavioural phenotype in a line of mice with targeted gene deletion of the D2 dopamine receptor. Neuropharmacology 39: 382–390. (10.1016/S0028-3908(99)00150-1) / Neuropharmacology by JJ Clifford (2000)
  8. Crabbe JC, Wahlsten D, Dudek BC (1999). Genetics of mouse behavior: interactions with laboratory environment. Science 284: 1670–1672. (10.1126/science.284.5420.1670) / Science by JC Crabbe (1999)
  9. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N et al (1997). Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 132: 107–124. (10.1007/s002130050327) / Psychopharmacology by JN Crawley (1997)
  10. Cromwell HC, Berridge KC, Drago J, Levine MS (1998). Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci 10: 2426–2432. (10.1046/j.1460-9568.1998.00250.x) / Eur J Neurosci by HC Cromwell (1998)
  11. Deveney AM, Waddington JL (1995). Pharmacological characterization of behavioural responses to SK&F 83959 in relation to ‘D1-like’ dopamine receptors not linked to adenylyl cyclase. Br J Pharmacol 116: 2120–2126. (10.1111/j.1476-5381.1995.tb16420.x) / Br J Pharmacol by AM Deveney (1995)
  12. Drago J, Gerfen CR, Lachowicz JE, Steiner H, Hollon TR, Love PE et al (1994). Altered striatal function in a mutant mouse lacking D1A dopamine receptors. Proc Natl Acad Sci USA 91: 12564–12568. (10.1073/pnas.91.26.12564) / Proc Natl Acad Sci USA by J Drago (1994)
  13. Gerlai R (1996). Gene-targeting studies of mammalian behaviour: is it the mutation or the background genotype. Trends Neurosci 19: 177–181. (10.1016/S0166-2236(96)20020-7) / Trends Neurosci by R Gerlai (1996)
  14. Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD (1995). Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat—relationship to circling behaviour. Biochem Pharmacol 49: 1185–1193. (10.1016/0006-2952(95)00035-X) / Biochem Pharmacol by KK Gnanalingham (1995)
  15. Kelly MA, Rubinstein M, Phillips TJ, Lessov CN, Burkhart-Kasch S, Zhang G et al (1998). Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J Neurosci 18: 3470–3479. (10.1523/JNEUROSCI.18-09-03470.1998) / J Neurosci by MA Kelly (1998)
  16. Kido Y, Philippe N, Schaffer AA, Accilli D (2000). Genetic modifiers of the insulin resistance phenotype in mice. Diabetes 49: 589–596. (10.2337/diabetes.49.4.589) / Diabetes by Y Kido (2000)
  17. Lariviere WR, Chesler EJ, Mogil JS (2001). Transgenic studies of pain and analgesia: mutation or background genotype? J Pharmacol Exp Ther 297: 467–473. / J Pharmacol Exp Ther by WR Lariviere (2001)
  18. Mahan LC, Burch RM, Monsma Jr FJ, Sibley DR (1990). Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes. Proc Natl Acad Sci USA 87: 2196–2200. (10.1073/pnas.87.6.2196) / Proc Natl Acad Sci USA by LC Mahan (1990)
  19. Moratalla R, Xu M, Tonegawa S, Graybiel AM (1996). Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor. Proc Natl Acad Sci USA 93: 14928–14933. (10.1073/pnas.93.25.14928) / Proc Natl Acad Sci USA by R Moratalla (1996)
  20. Nadeau JH (2001). Modifier genes in mice and humans. Nat Rev Genet 2: 165–174. (10.1038/35056009) / Nat Rev Genet by JH Nadeau (2001)
  21. Niznik HB, Sugamori KS, Clifford JJ, Waddington JL (2002). D1-like dopamine receptors: molecular biology and pharmacology. In: Di Chiara G (ed). Handbook of Experimental Pharmacology: Dopamine in the CNS. Springer: Heidelberg, 121–158. / Handbook of Experimental Pharmacology: Dopamine in the CNS by HB Niznik (2002)
  22. Panchalingham S, Undie AS (2001). SKF 83959 exhibits biochemical agonism by stimulating [35S]GTPγS binding and phos-phoinositide hydrolysis in rat and monkey brain. Neuropharmacology 40: 826–837. (10.1016/S0028-3908(01)00011-9) / Neuropharmacology by S Panchalingham (2001)
  23. Phillips TJ, Hen R, Crabbe JC (1999). Complications associated with genetic background effects in research using knockout mice. Psychopharmacology (Berl) 147: 5–7. (10.1007/s002130051128) / Psychopharmacology (Berl) by TJ Phillips (1999)
  24. Ralph RJ, Paulus MP, Geyer MA (2001). Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice. J Pharmacol Exp Ther 298: 148–155. / J Pharmacol Exp Ther by RJ Ralph (2001)
  25. Rogers DC, Jones DN, Nelson PR, Jones CM, Quilter CA, Robinson TL et al (1999). Use of SHIRPA and discriminant analysis to characterise marked differences in the behavioural phenotype of six inbred mouse strains. Behav Brain Res 105: 207–217. (10.1016/S0166-4328(99)00072-8) / Behav Brain Res by DC Rogers (1999)
  26. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L et al (2000). Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA 97: 11038–11043. (10.1073/pnas.97.20.11038) / Proc Natl Acad Sci USA by R Sandberg (2000)
  27. Sanford LP, Kallapur S, Ormsby I, Doetschman T (2001). Influence of genetic background on knockout mouse phenotypes. In: Tymms MJ, Kola I (eds). Gene Knockout Protocols. Humana Press Inc: Totowa, NJ, 217–226. (10.1385/1-59259-220-1:217) / Gene Knockout Protocols by LP Sanford (2001)
  28. Sibley DR (1999). New insights into dopaminergic receptor function using antisense and genetically altered animals. Annu Rev Pharmacol Toxicol 39: 313–341. (10.1146/annurev.pharmtox.39.1.313) / Annu Rev Pharmacol Toxicol by DR Sibley (1999)
  29. Smith DR, Striplin CD, Geller AM, Mailman RB, Drago J, Lawler CP et al (1998). Behavioural assessment of mice lacking D1A dopamine receptors. Neuroscience 86: 135–146. (10.1016/S0306-4522(97)00608-8) / Neuroscience by DR Smith (1998)
  30. Undie AS, Friedman E (1990). Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. J Pharmacol Exp Ther 253: 987–992. / J Pharmacol Exp Ther by AS Undie (1990)
  31. Undie AS, Weinstock J, Sarau HM, Friedman E (1994). Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62: 2045–2048. (10.1046/j.1471-4159.1994.62052045.x) / J Neurochem by AS Undie (1994)
  32. Waddington JL, Clifford JJ, McNamara FN, Tomiyama K, Koshikawa N, Croke DT (2001). The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion (‘knockout’). Prog Neuropsychopharmacol Biol Psychiatry 25: 925–964. (10.1016/S0278-5846(01)00152-X) / Prog Neuropsychopharmacol Biol Psychiatry by JL Waddington (2001)
  33. Waddington JL, Daly SA, McCauley PG, O'Boyle KM (1994). Levels of functional interaction between D1-like and D2-like dopamine receptor systems. In: Niznik HB (ed). Dopamine Receptors and Transporters. Marcel Dekker: New York, 511–537. / Dopamine Receptors and Transporters by JL Waddington (1994)
  34. Waddington JL, Deveney AM, Clifford J, Tighe O, Croke DT, Sibley DR et al (1998). D1-like dopamine receptors: regulation of psychomotor behaviour, D1-like:D2-like interactions and effects of D1A targeted gene deletion. In: Jenner P, Demirdamar R (eds). Dopamine Receptor Subtypes. IOS Press: Amsterdam, 45–53. / Dopamine Receptor Subtypes by JL Waddington (1998)
  35. Xu M, Hu XT, Cooper DC, Moratalla R, Graybiel AM, White FJ et al (1994a). Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice. Cell 79: 945–955. (10.1016/0092-8674(94)90026-4) / Cell by M Xu (1994)
  36. Xu M, Moratalla R, Gold LH, Hiroi N, Koob GF, Graybiel AM et al (1994b). Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell 79: 729–742. (10.1016/0092-8674(94)90557-6) / Cell by M Xu (1994)
Dates
Type When
Created 22 years, 6 months ago (Feb. 20, 2003, 1:06 p.m.)
Deposited 2 years, 3 months ago (May 16, 2023, 3:43 a.m.)
Indexed 2 months, 2 weeks ago (June 16, 2025, 10:28 a.m.)
Issued 23 years, 2 months ago (June 14, 2002)
Published 23 years, 2 months ago (June 14, 2002)
Published Online 23 years, 2 months ago (June 14, 2002)
Published Print 22 years, 8 months ago (Jan. 1, 2003)
Funders 0

None

@article{McNamara_2002, title={Congenic D1A Dopamine Receptor Mutants: Ethologically Based Resolution of Behavioural Topography Indicates Genetic Background as a Determinant of Knockout Phenotype}, volume={28}, ISSN={1740-634X}, url={http://dx.doi.org/10.1038/sj.npp.1300008}, DOI={10.1038/sj.npp.1300008}, number={1}, journal={Neuropsychopharmacology}, publisher={Springer Science and Business Media LLC}, author={McNamara, Fergal N and Clifford, Jeremiah J and Tighe, Orna and Kinsella, Anthony and Drago, John and Croke, David T and Waddington, John L}, year={2002}, month=jun, pages={86–99} }